Lancet

• Latest
• Best
• Search…

• Lancet · Jan 2023

  An imaging pitfall: misdiagnosis of pulmonary embolism in a patient with advanced cystic fibrosis and bronchiectasis.

  no abstract available

  read on… or not…

• Lancet · Jan 2023

  Comment Letter

  Improving childhood cancer care in China - Authors' reply.

  no abstract available

  read on… or not…

• Lancet · Jan 2023

  Comment

  Gaining MOMENTUM against anaemic myelofibrosis.

  no abstract available

  expand abstract… mark as read…

• Lancet · Jan 2023

  Comment Letter

  Medicine should be learned in a conducive environment.

  no abstract available

  keep reading… or not…

• Lancet · Jan 2023

  Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.

  WHO has identified Marburg virus as an emerging virus requiring urgent vaccine research and development, particularly due to its recent emergence in Ghana. We report results from a first-in-human clinical trial evaluating a replication-deficient recombinant chimpanzee adenovirus type 3 (cAd3)-vectored vaccine encoding a wild-type Marburg virus Angola glycoprotein (cAd3-Marburg) in healthy adults. ⋯ National Institutes of Health.

  read more… mark as read…